Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Research To Practice | Oncology Videos · Dr. Neil Love
May 3, 202459m 47s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Prof Eric Van Cutsem, including the following topics:
Immune Checkpoint Inhibitors in Localized Gastroesophageal (GE) Cancers
- Introduction (0:00)
- Case: A man in his mid 50s with localized, poorly differentiated signet ring, mismatch repair-deficient advanced gastric adenocarcinoma — Sunnie Kim, MD (3:39)
HER2-Positive GE Cancers
- Case: A man in his early 70s with HER2-positive gastroesophageal junction (GEJ) adenocarcinoma and disease progression on FOLFOX/trastuzumab (PD-L1 CPS 0) — Dr Kim (19:22)
First-Line Treatment of Metastatic Gastric and GEJ Adenocarcinoma
- Case: A man in his early 40s who presents with metastatic GEJ adenocarcinoma (CLDN18.2-positive, PD-L1 CPS 2) in visceral crisis from lung metastases — Dr Kim (38:53)
- Case: A man in his mid 60s with metastatic GEJ adenocarcinoma (PD-L1 CPS 20) — Dr Kim (50:50)